The most common abortion method in the US is at risk of disappearing from the market, at least temporarily, after a Texas judge granted an injunction against the US Food and Drug Administration’s decades-old approval for mifepristone, also known as the abortion pill.
The preliminary injunction issued Friday by US District Judge Matthew Kacsmaryk, who was appointed by President Donald Trump, could soon end the sale and distribution of mifepristone — used as part of a two-pill regimen to terminate a pregnancy within the first 10 weeks — while a lawsuit seeking a more permanent ban on the drug proceeds. The Biden administration has ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.